Economics of One Health: Costs and benefits of integrated West Nile virus surveillance in Emilia-Romagna

PLoS ONE

Volumn 12, Issue 11, 2017, Pages

  Paternoster, Giulia ^a,i   Martins, Sara Babo ^b,c   Mattivi, Andrea ^d   Cagarelli, Roberto ^d   Angelini, Paola ^d   Bellini, Romeo ^e   Santi, Annalisa ^a   Galletti, Giorgio ^a   Pupella, Simonetta ^f   Marano, Giuseppe ^f   Copello, Francesco ^g   Rushton, Jonathan ^h   Stärk, Katharina D C ^b,c   Tamba, Marco ^a  

^a ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL EMILIA ROMAGNA   (Italy)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c Bern Liebefeld   (Switzerland)

^d Drug Policy Service   (Italy)

^e Centro Agricoltura Ambiente G Nicoli   (Italy)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h UNIVERSITY OF LIVERPOOL   (United Kingdom)

ⁱ UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DISEASE SURVEILLANCE; ECONOMICS; HEALTH CARE COST; HUMAN; ITALY; NONHUMAN; VIRUS TRANSMISSION; WEST NILE VIRUS; ADULT; AGED; BLOOD COMPONENT THERAPY; FEMALE; HEALTH SURVEY; HOSPITALIZATION; MALE; MIDDLE AGED; ONE HEALTH; PHYSIOLOGY; VERY ELDERLY; VIROLOGY; WEST NILE FEVER;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COMPONENT TRANSFUSION; COST-BENEFIT ANALYSIS; FEMALE; HOSPITALIZATION; HUMANS; ITALY; MALE; MIDDLE AGED; ONE HEALTH; POPULATION SURVEILLANCE; WEST NILE FEVER; WEST NILE VIRUS;

EID: 85035229655     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0188156     Document Type: Article

References (32)

1. Macini P, Squintani G, Finarelli AC, Angelini P, Martini E, Tamba M, et al. Detection of West Nile virus infection in horses, Italy, September 2008. Euro Surveill. 2008; 13(41):pii = 19002. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19002
2. Rossini G, Cavrini F, Pierro A, Macini P, Finarelli A, Po C, et al. First human case of West Nile virus neuroinvasive infection in Italy, September 2008—case report. Euro Surveill. 2008; 13(41):pii = 19002. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19002
3. Bellini R, Calzolari M, Mattivi A, Tamba M, Angelini P, Bonilauri P, et al. The experience of West Nile virus integrated surveillance system in the Emilia-Romagna region: five years of implementation, Italy, 2009 to 2013. Euro Surveill. 2014; 19(44): pii = 20953. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20953
4. Emilia-Romagna Region. Piano di sorveglianza e controllo malattia West Nile, Chickungunya e Dengue e altri arbovirus in Emilia-Romagna, anno 2013. [Regional surveillance plan for West Nile Disease, Chickungunya, Dengue and other arboviruses in Emilia-Romagna, year 2013]. 2013. Available online: http://salute.regione.emilia-romagna.it/documentazione/piani-e-programmi/piano_arbovirosi_rer_2013.pdf
5. Emilia-Romagna Region. Piano sorveglianza arbovirosi 2014 [Regional arboviruses surveillance plan 2014]. 2014. Available online: http://www.izsler.it/izs_bs/allegati/736/PIANO SORVEGLIANZA ARBOVIROSI 2014.pdf
6. Emilia-Romagna Region. Piano sorveglianza arbovirosi 2015 [Regional arboviruses surveillance plan 2015]. 2015. Available online: http://www.zanzaratigreonline.it/Portals/zanzaratigreonline/PianoregionaleSorveglianzaArbovirosi2015.pdf
7. European Commission. Commission Directive 2014/110/EU of 17 December 2014 amending Directive 2004/33/EC as regards temporary deferral criteria for donors of allogeneic blood donations. Official Journal of the European Union. Luxembourg: Publications Office of the European Union. 20.12.2014 L 366. 2014.
8. Tisdell C. Economics of Controlling Livestock Diseases: Basic Theory. In: Rushton J, editor. Economics of Animal Health & Production. Wallingford, UK: CABI; 2009. p. 46–9.
9. Babo Martins S, Rushton J, Stärk KDC. Economic Assessment of Zoonoses Surveillance in a “One Health” Context: A Conceptual Framework. Zoonoses Public Health. 2016; 63(5):386–95. https://doi.org/10.1111/zph.12239 PMID: 26607752
10. Napoli C, Iannetti S, Rizzo C, Bella A, Di Sabatino D, Bruno R, et al. Vector borne infections in Italy: results of the integrated surveillance system for West Nile disease in 2013. Biomed Res Int. 2015; 2015:643439. Available online: https://www.hindawi.com/journals/bmri/2015/643439/ https://doi.org/10.1155/2015/643439 PMID: 25874224
11. Pisani G, Cristiano K, Pupella S, Liumbruno GM. West Nile Virus in Europe and Safety of Blood Transfusion. Transfus Med Hemotherapy. 2016; 43(3):158–67. Available online: http://www.ncbi.nlm.nih.gov/pubmed/27403087
12. Angelini P, Tamba M, Finarelli AC, Bellini R, Albieri A, Bonilauri P, et al. West Nile virus circulation in Emilia-Romagna, Italy: the integrated surveillance system 2009. Euro Surveill. 2010; 15(16):19547. PMID: 20430000.
13. Calzolari M, Gaibani P, Bellini R, Defilippo F, Pierro A, Albieri A, et al. Mosquito, bird and human surveillance of West Nile and Usutu viruses in Emilia-Romagna Region (Italy) in 2010. PLoS ONE. 2012; 7(5): e38058. Available online: https://doi.org/10.1371/journal.pone.0038058 PMID: 22666446
14. Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia-Romagna (IZSLER). Tariffario presta-zioni di laboratorio [Laboratory price list]. Available online: http://www.izsler.it/izs_bs/ftp/materiali_ftp/tariffarioIZSLER.pdf
15. Emilia-Romagna Region. Progetto per la realizzazione di un sistema integrato di sorveglianza sanitaria delle malattie trasmesse da artropodi vettori in Emilia-Romagna. Assegnazione e concessione finanziamento all’azienda USL della Romagna. [Regional project for the integrated surveillance of vector-borne diseases in Emilia-Romagna. Assignment of funding to the Romagna Local Health Unit]. GPG/2015/ 494. Bologna; 2015.
16. Emilia-Romagna Region. Progetto per la realizzazione di un sistema integrato di sorveglianza sanitaria delle malattie trasmesse da artropodi vettori in Emilia-Romagna. Assegnazione e concessione finanziamento all’azienda USL della Romagna. [Regional project for the integrated surveillance of vector-borne diseases in Emilia-Romagna. Assignment of funding to the Romagna Local Health Unit]. GPG/2014/ 396. Bologna; 2014.
17. Canali M, Rivas S. Controllo della Zanzara-Tigre: analisi dei costi sostenuti dagli Enti Locali. Emilia-Romagna Report 2008–2011 [Emilia-Romagna report on the costs allocated for tiger mosquito control activities by the Local Health Units, 2008–2011]. Bologna; 2012; 45–46.
18. Ministero della Salute. [Italian Ministry of Health]. West Nile Disease. Procedure operative di intervento e flussi informativi nell’ambito del Piano di sorveglianza nazionale per la Encefalomielite di tipo West Nile (West Nile Disease), anno 2014 [West Nile Disease: procedures and information flow within the National surveillance plan for equine West Nile virus neurologic disease, year 2014]. 2014; Available online: http://www.gazzettaufficiale.it/eli/id/2014/07/18/14A05608/sg
19. World Health Organization (WHO). West Nile virus Fact sheet No. 354. 2011. Available online: http://www.who.int/mediacentre/factsheets/fs354/en/ last access 06/09/2017
20. Ministero della Salute. [Italian Ministry of Health]. Indennizzo a favore dei soggetti danneggiati da com-plicanze di tipo irreversibile a causa di vaccinazioni obbligatorie, trasfusioni [Compensation for individuals harmed by irreversible complications resulting from compulsory vaccinations, transfusions and the administration of blood derivatives]. National law 210/1992; Available online http://www.salute.gov.it/imgs/C_17_normativa_1556_allegato.pdf
21. Ministero della Salute. [Italian Ministry of Health]. Tabella importi indennizzo rivalutati fino all’anno 2017 [Tables of the amount of the compensation according to the National law 210/1992, values updated until the year 2017]. Available online: http://www.indennizzolegge210.it/detail.asp?c=13&p=0&id=905
22. Gossner CM, Marrama L, Carson M, Allerberger F, Calistri P, Dilaveris D, et al. West nile virus surveillance in Europe: Moving towards an integrated animal-human-vector approach. Euro Surveill. 2017; 22 (18):pii = 30526. https://doi.org/http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2017.22.18.30526
23. Humblet M, Vandeputte S, Fecher-Bourgeois F, Léonard P, Gosset C, Balenghien T, et al. Estimating the economic impact of a possible equine and human epidemic of West Nile virus infection in Belgium. Euro Surveill. 2016; 21(31):pii = 30309. https://doi.org/https://doi.org/10.2807/1560-7917.ES.2016.21.31.30309
24. Kolimenakis A, Bithas K, Richardson C, Latinopoulos D, Baka A, Vakali A, et al. Economic appraisal of the public control and prevention strategy against the 2010 West Nile Virus outbreak in Central Macedonia, Greece. Public Health. 2016; 131:63–70. Available online: http://dx.doi.org/10.1016/j.puhe.2015.10.023
25. Staples JE, Shankar MB, Sejvar JJ, Meltzer MI, Fischer M. Initial and long-term costs of patients hospitalized with West Nile virus disease. Am J Trop Med Hyg. 2014; 90(3):402–9. Available online: http://www.ajtmh.org/content/90/3/402.long https://doi.org/10.4269/ajtmh.13-0206 PMID: 24515937
26. European central bank, Euro foreign exchange reference rates https://www.ecb.europa.eu/stats/policy_and_exchange_rates/euro_reference_exchange_rates/html/index.en.html, last access 08/03/ 2017
27. Barber LM, Schleier JJ, Peterson RKD. Economic Cost Analysis of West Nile Virus Outbreak, Sacramento County, California, USA, 2005. Emerg Infect Dis. 2010; 16(3):480–6. Available online: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3322011&tool=pmcentrez&rendertype=abstract https://doi.org/10.3201/eid1603.090667 PMID: 20202424
28. Zohrabian A, Hayes EB, Petersen LR. Cost-effectiveness of West Nile virus vaccination. Emerg Infect Dis. 2006; 12(3):375–80. Available online: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3291438&tool=pmcentrez&rendertype=abstract https://doi.org/10.3201/eid1203.050782 PMID: 16704772
29. Zohrabian A, Meltzer MI, Ratard R, Billah K, Molinari NA, Roy K, et al. West Nile virus economic impact, Louisiana, 2002. Emerg Infect Dis. 2004; 10(10):1736–44. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323281/ https://doi.org/10.3201/eid1010.030925 PMID: 15504258
30. Bellini R, Zeller H, Van Bortel W. A review of the vector management methods to prevent and control outbreaks of West Nile virus infection and the challenge for Europe. Parasit Vectors. 2014; 7:323. Available online: http://www.parasitesandvectors.com/content/7/1/323 https://doi.org/10.1186/1756-3305-7-323 PMID: 25015004
31. Korves CT, Goldie SJ, Murray MB. Cost-effectiveness of alternative blood-screening strategies for West Nile virus in the United States. PLoS Med. 2006; 3(2):0211–21. Available online: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0030021
32. Niederhauser C, Fontana S, Glauser A, Steinemann C, Koller A. West Nile Virus preparedness plan to ensure safe blood components in Switzerland: a risk-based approach. 2016;1–8. Available online: http://onlinelibrary.wiley.com/doi/10.1111/voxs.12300/pdf